CDTX vs CSGP · rev $1.3M vs P/E 484, rev $2.74B
Cidara Therapeutics Inc (CDTX) versus CoStar Group Inc (CSGP) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
CoStar Group Inc (CSGP) is a real estate services company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported CSGP revenue for 2024-12-31 was $2.74B. Net income was $138.7M. Revenue was up 11.5% from 2023-12-31 to 2024-12-31. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
CDTX currently screens at market cap $6.96B. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
Not investment advice. Open the CDTX and CSGP stock pages for the full models.
Not investment advice.